• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

获得性免疫缺陷综合征患者中新隐球菌分离株的体外药敏试验

In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome.

作者信息

Poon M, Cronin D C, Wormser G P, Bottone E J

机构信息

Department of Microbiology, Mount Sinai Medical Center, New York, NY 10029-6574.

出版信息

Arch Pathol Lab Med. 1988 Feb;112(2):161-2.

PMID:3276290
Abstract

Cryptococcus neoformans strains from 26 individual patients with acquired immunodeficiency syndrome (AIDS) and three isolates from patients without AIDS were tested for their susceptibility to amphotericin B, flucytosine, ketoconazole, and miconazole nitrate. Ninety percent of the C neoformans isolates from patients with AIDS were inhibited by drug concentrations within achievable serum levels. The minimum fungicidal concentration of the four tested antifungal agents, however, exceeded obtainable cerebrospinal fluid levels.

摘要

对来自26例获得性免疫缺陷综合征(AIDS)患者的新型隐球菌菌株以及3例非AIDS患者的分离株进行了两性霉素B、氟胞嘧啶、酮康唑和硝酸咪康唑的药敏试验。来自AIDS患者的新型隐球菌分离株中有90%在可达到的血清浓度下受到抑制。然而,四种受试抗真菌药物的最低杀菌浓度超过了可获得的脑脊液浓度。

相似文献

1
In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome.获得性免疫缺陷综合征患者中新隐球菌分离株的体外药敏试验
Arch Pathol Lab Med. 1988 Feb;112(2):161-2.
2
In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.马来西亚新型隐球菌格鲁比变种和加蒂隐球菌临床分离株对五种抗真菌药物的体外敏感性
Mycoses. 2006 Jul;49(4):324-30. doi: 10.1111/j.1439-0507.2006.01242.x.
3
In vitro susceptibility of Cryptococcus neoformans clinical isolates from Egypt to seven antifungal drugs.埃及新型隐球菌临床分离株对七种抗真菌药物的体外敏感性
Mycoses. 2005 Sep;48(5):327-32. doi: 10.1111/j.1439-0507.2005.01137.x.
4
Antifungal drug combinations for Cryptococcus neoformans and Prototheca spp.用于新型隐球菌和原藻属的抗真菌药物联合疗法
J Med Assoc Thai. 2000 Jan;83(1):57-60.
5
5-Fluorocytosine resistance in clinical isolates of Cryptococcus neoformans.新型隐球菌临床分离株对5-氟胞嘧啶的耐药性
Med J Malaysia. 1989 Sep;44(3):194-8.
6
[Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].[血液和脑脊液中酵母分离株抗真菌药敏试验的微量肉汤稀释法研究]
Rinsho Byori. 1996 Apr;44(4):373-8.
7
Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.新型隐球菌:A/D 血清型和 B/C 血清型体外抗真菌药敏性比较
Mycopathologia. 1986 Apr;94(1):27-30. doi: 10.1007/BF00437258.
8
Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.新型隐球菌体外药敏试验中肉汤稀释法与半固体琼脂稀释法的比较。
J Chemother. 1994 Jun;6(3):173-6. doi: 10.1080/1120009x.1994.11741148.
9
Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans.两性霉素B与氟胞嘧啶联合使用在体外对氟胞嘧啶耐药的新型隐球菌分离株具有活性。
Antimicrob Agents Chemother. 2007 Jan;51(1):383-5. doi: 10.1128/AAC.00446-06. Epub 2006 Oct 16.
10
Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya.肯尼亚内罗毕临床来源新生隐球菌的抗真菌药敏性
Mycoses. 2007 Jan;50(1):25-30. doi: 10.1111/j.1439-0507.2006.01293.x.

引用本文的文献

1
In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs.新型隐球菌临床分离株和环境分离株对五种抗真菌药物的体外敏感性
Antimicrob Agents Chemother. 1996 Mar;40(3):822-4. doi: 10.1128/AAC.40.3.822.